Candel therapeutics announces upcoming clinical data presentations at sitc and sno

Needham, mass., nov. 07, 2022 (globe newswire) -- candel therapeutics, inc. (nasdaq: cadl), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced new clinical data will be presented in the upcoming 37th annual meeting of the society for immunotherapy of cancer (sitc) in boston, ma and the 27th annual meeting of the society for neuro-oncology (sno) in tampa bay, fl.
CADL Ratings Summary
CADL Quant Ranking